Avanos Medical, Inc. (AVNS) Tops Q4 EPS by 2c

Avanos Medical, Inc. (NYSE: AVNS) reported Q4 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $190 million versus the consensus estimate of $181.07 million.

2020 Key Planning Assumptions

The company expects 2020 net sales to increase 5 to 7 percent, on a constant currency basis, compared to 2019 and earn between $1.00 and $1.20 of adjusted diluted earnings per share. This outlook reflects certain key assumptions, which are listed below:

The Company expects the foreign currency translation impact to be even compared to the prior year.
The adjusted effective tax rate is anticipated to be between 25 and 27 percent.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.

You May Also Be Interested In

• Wex, Inc. (WEX) Tops Q2 EPS by 29c; raises guidance
• MindWalk (HYFT) Misses Q4 EPS by 8c
• Oceaneering (OII) Tops Q2 EPS by 19c